Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the european organization for research and treatment of cancer lung cancer cooperative group (EORTC 08955)
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
In patients with N2 stage IIIA NSCLC, GC is a highly active and well-tolerated induction regimen. GC should be explored in combination with surgery or radiotherapy in stage I and II patients.